Publikationen in Zusammenarbeit mit Forschern von Hospital Universitario 12 de Octubre (19)

2023

  1. Testing the performance, adequacy, and applicability of an artificial intelligence model for pediatric pneumonia diagnosis

    Computer Methods and Programs in Biomedicine, Vol. 242

2022

  1. A Tool to Distinguish Viral from Bacterial Pneumonia

    Pediatric Infectious Disease Journal, Vol. 41, Núm. 1, pp. 31-36

  2. Comparison of pneumonia features in children caused by SARS-CoV-2 and other viral respiratory pathogens

    Pediatric Pulmonology, Vol. 57, Núm. 10, pp. 2374-2382

  3. Viruses and Mycoplasma pneumoniae are the main etiological agents of community-acquired pneumonia in hospitalized pediatric patients in Spain

    Pediatric pulmonology, Vol. 57, Núm. 1, pp. 253-263

2021

  1. Diagnostic Accuracy of the Panbio Severe Acute Respiratory Syndrome Coronavirus 2 Antigen Rapid Test Compared with Reverse-Transcriptase Polymerase Chain Reaction Testing of Nasopharyngeal Samples in the Pediatric Population

    Journal of Pediatrics, Vol. 232, pp. 287-289.e4

  2. Interferon-Gamma Release Assays Differentiate between Mycobacterium avium Complex and Tuberculous Lymphadenitis in Children

    Journal of Pediatrics, Vol. 236, pp. 211-218.e2

  3. Prevalence of thrombotic complications in children with SARS-CoV-2

    Archives of Disease in Childhood, Vol. 106, Núm. 11, pp. 1129-1132

  4. Screening and Severity of Coronavirus Disease 2019 (COVID-19) in Children in Madrid, Spain

    JAMA Pediatrics

  5. Ventricular Repolarization Parameters and Coronary Involvement in Kawasaki Disease

    Journal of Pediatrics, Vol. 236, pp. 108-112.e5

2020

  1. Epidemiological update on SARS-CoV-2 infection in Spain. Comments on the management of infection in pediatrics

    Anales de Pediatria, Vol. 92, Núm. 4, pp. 239-240

2017

  1. Dexamethasone for Parapneumonic Pleural Effusion: A Randomized, Double-Blind, Clinical Trial

    Journal of Pediatrics, Vol. 185, pp. 117-123.e6

  2. Effect of the different 13-valent pneumococcal conjugate vaccination uptakes on the invasive pneumococcal disease in children: Analysis of a hospital-based and population-based surveillance study in Madrid, Spain, 2007-2015

    PLoS ONE, Vol. 12, Núm. 2

  3. Impact of 13-valent pneumococcal conjugate vaccine on pneumococcal meningitis in children

    Vaccine, Vol. 35, Núm. 35, pp. 4646-4651

2015

  1. Hemophagocytic Lymphohistiocytosis in Children with Visceral Leishmaniasis

    Pediatric Infectious Disease Journal, Vol. 34, Núm. 6, pp. 667-669

2013

  1. Expansion of serotype coverage in the universal pediatric vaccination calendar: Short-term effects on age- and serotype-dependent incidence of invasive pneumococcal clinical presentations in Madrid, Spain

    Clinical and Vaccine Immunology, Vol. 20, Núm. 10, pp. 1524-1530

  2. Impact of introduction of conjugate vaccines in the vaccination schedule on the incidence of pediatric invasive pneumococcal disease requiring hospitalization in Madrid 2007 to 2011

    Pediatric Infectious Disease Journal

  3. Oseltamivir treatment for influenza in hospitalized children without underlying diseases

    Pediatric Infectious Disease Journal, Vol. 32, Núm. 10, pp. 1066-1069

2011

  1. Relationship between serotypes, age, and clinical presentation of invasive pneumococcal disease in Madrid, Spain, after introduction of the 7-valent pneumococcal conjugate vaccine into the vaccination calendar

    Clinical and Vaccine Immunology, Vol. 18, Núm. 1, pp. 89-94

2002

  1. Meningitis neumocócica en niños Españoles: Incidencia, serotipos y resistencia antibiótica. Estudio prospectivo multicéntrico

    Anales Espanoles de Pediatria, Vol. 57, Núm. 4, pp. 295-300